Dexpak Taperpak Interactions
There are 820 drugs known to interact with Dexpak Taperpak (dexamethasone), along with 23 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 166 are major, 598 are moderate, and 56 are minor.
- View all 820 medications that may interact with Dexpak Taperpak
- View Dexpak Taperpak alcohol/food interactions (2)
- View Dexpak Taperpak disease interactions (23)
Most frequently checked interactions
View interaction reports for Dexpak Taperpak (dexamethasone) and the medicines listed below.
- Aleve (naproxen)
- Allegra (fexofenadine)
- amoxicillin
- atorvastatin
- azithromycin
- cefdinir
- clonazepam
- doxycycline
- Dymista (azelastine / fluticasone nasal)
- gabapentin
- Lexapro (escitalopram)
- Linzess (linaclotide)
- Lopressor (metoprolol)
- magnesium oxide
- melatonin
- meloxicam
- metformin
- minocycline
- mirtazapine
- Morphine Sulfate ER (morphine)
- Nexium (esomeprazole)
- Norvasc (amlodipine)
- oxycodone
- pantoprazole
- Pataday (olopatadine ophthalmic)
- potassium gluconate
- pravastatin
- prednisone
- tramadol
- zolpidem
Dexpak Taperpak alcohol/food interactions
There are 2 alcohol/food interactions with Dexpak Taperpak (dexamethasone).
Dexpak Taperpak disease interactions
There are 23 disease interactions with Dexpak Taperpak (dexamethasone) which include:
- infections
- prematurity
- (+) tuberculin test
- cirrhosis
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hyperlipidemia
- hypothyroidism
- liver disease
- MI
- myasthenia gravis
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- scleroderma
- strongyloidiasis
- thromboembolism
Report options
More about Dexpak Taperpak (dexamethasone)
- Dexpak Taperpak consumer information
- Compare alternatives
- Reviews (1)
- Latest FDA alerts (9)
- Side effects
- Dosage information
- During pregnancy
- Drug class: glucocorticoids
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Benlysta
Benlysta infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Nplate
Nplate is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.